PET-CT: reliable cornerstone for Hodgkin lymphoma treatment?
- PMID: 27013209
- DOI: 10.1182/blood-2016-01-692111
PET-CT: reliable cornerstone for Hodgkin lymphoma treatment?
Abstract
In this issue of Blood, Barrington et al present the analyses of centrally reviewed positron emission tomography-computed tomography (PET-CT) used for staging and response monitoring after 2 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) to guide treatment modification in a large prospective clinical trial in Hodgkin lymphoma (HL) (Response-Adapted Therapy in Advanced Hodgkin Lymphoma [RATHL]).
Comment on
-
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.Blood. 2016 Mar 24;127(12):1531-8. doi: 10.1182/blood-2015-11-679407. Epub 2016 Jan 8. Blood. 2016. PMID: 26747247
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

